Rheumatoid Arthritis
From the Journals
Making Repeated Treatment Changes May Help Resolve Difficult-to-Treat RA
A new study showed that continued treatment modifications made over a 5-year period could help to resolve difficult-to-treat rheumatoid arthritis...
From the Journals
Baricitinib Outperforms TNF Inhibitors in Real-World RA Trial
In a real-world trial, baricitinib was favored over TNF inhibitors in clinical and patient-reported outcomes after 12 weeks, but one expert...
Conference Coverage
Selective JAK 1 Inhibitor for RA Proves Promising in Phase 3 Trial
SHR0302 (ivarmacitinib) is highly selective for JAK 1 and the first JAK inhibitor to be originally developed and now tested in a phase 3 RA...
Conference Coverage
Long-Term OA, RA Symptom Improvement Seen with Plant-Based Diet, Lifestyle Changes
The intervention for patients with OA and RA led to improved pain and stiffness, as well as improved disease activity. Mechanisms were thought to...
Conference Coverage
Timing Pneumococcal Vaccination in Patients with RA Starting Methotrexate: When’s Best?
Vaccinating against pneumococcal infection prior to starting methotrexate improved humoral response and starting methotrexate 1 month later did...
Conference Coverage
Low Infection Risk, Apart from Herpes Zoster, Seen in Real-World JAK Inhibitor Data for RA
The only infection risk in patients with RA that is higher with Janus kinase inhibitors relative to biologics is herpes zoster, according to...
From the Journals
Having More Tender Than Swollen Joints Worsens Outcomes in Early Rheumatoid Arthritis
Patients with early rheumatoid arthritis who had higher tender-swollen joint differences showed deteriorating patient-reported outcomes over a 1-...
Conference Coverage
EULAR 2024 Preview: Therapeutics in Development Take Center Stage
Experts give their top picks and hot tips on data being presented at the upcoming European Congress of Rheumatology taking place on June 12-15 in...
From the Journals
Clear Coverage Preference for Humira Over Biosimilars Seen in Most Medicare Part D Plans
This narrow coverage limits the cost-saving potential of these biosimilar competitors, the authors of a new study said.
Latest News
Over-the-Counter Arthritis Supplements Pose Adrenal Danger
Patients taking OTC arthritis supplements may need to taper use to avoid adrenal insufficiency, dysfunction, says presenter.
From the Journals
No Increased Risk for Fractures Seen With Frequent Steroid Injections for Musculoskeletal Conditions
Fracture risk was not associated with the cumulative dose of injected corticosteroids in patients receiving the shots for musculoskeletal pain,...